	Jun'05	Jun'06	Jun'07	Jun'08	Jun'09	Jun'10	Jun'11	Jun'12	Jun'13	Jun'14	Jun'15	Jun'16	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24
Revenue % growth	425.5 25.4%	607.0 42.7%	716.3 18.0%	835.4 16.6%	920.7 10.2%	1,092.4 18.6%	1,243.1 13.8%	1,368.5 10.1%	1,514.5 10.7%	1,555.0 2.7%	1,678.9 8.0%	1,838.7 9.5%	2,066.7 12.4%	2,340.2 13.2%	2,606.6 11.4%	2,957.0 13.4%	3,196.8 8.1%	3,578.1 11.9%	4,223.0 18.0%	4,685.3 10.9%
Cost of Goods Sold (COGS)	150.6	230.1	331.8	341.6	366.9	436.9	501.8	547.8	573.8	565.2	667.5	772.2	865.0	978.0	1,070.0	1,239.2	1,357.7	1,553.8	1,867.3	2,030.0
Gross Profit % margin	274.9 64.6%	376.9 62.1%	384.5 53.7%	493.8 59.1%	553.8 60.1%	655.5 60.0%	741.3 59.6%	820.7 60.0%	940.7 62.1%	989.8 63.7%	1,011.4 60.2%	1,066.5 58.0%	1,201.7 58.1%	1,362.2 58.2%	1,536.6 59.0%	1,717.8 58.1%	1,839.1 57.5%	2,024.3 56.6%	2,355.7 55.8%	2,655.3 56.7%
Operating Expenses	167.1	244.5	294.3	348.4	360.0	412.1	473.4	525.3	585.8	578.4	596.2	625.2	745.0	801.9	900.6	908.7	926.7	1,024.0	1,203.7	1,335.4
Research & Development Expenses (R&D)	30.0	37.2	50.1	60.5	63.1	75.2	92.0	109.7	120.1	118.2	114.9	118.7	144.5	155.1	180.7	201.9	225.3	253.6	287.6	307.5
Selling, General & Administrative Expenses (SG&A)	135.7	200.2	237.3	278.1	289.9	328.9	371.2	401.6	430.8	450.4	472.6	482.6	554.0	600.4	645.0	676.7	670.4	739.4	874.0	917.1
Operating Income % margin	97.4 22.9%	131.3 21.6%	90.2 12.6%	143.0 17.1%	190.3 20.7%	240.4 22.0%	266.9 21.5%	294.4 21.5%	354.8 23.4%	405.1 26.1%	409.2 24.4%	429.0 23.3%	425.8 20.6%	541.8 23.2%	579.3 22.2%	809.7 27.4%	903.7 28.3%	1,000.3 28.0%	1,131.9 26.8%	1,319.9 28.2%
Interest Income	0.0	0.0	0.0	0.0	0.0	16.7	27.8	33.9	38.9	31.2	26.2	16.9	17.1	16.4	2.3	1.0	0.4	22.3	47.4	0.0
Interest Expense	0.0	1.3	1.3	10.1	10.1	10.1	1.8	4.8	6.4	6.1	5.8	11.2	28.2	28.4	36.2	40.4	24.0	22.3	47.4	45.7
Pre-tax Income	96.6	133.4	98.0	157.9	201.7	260.6	303.7	331.9	385.1	431.1	435.9	439.6	418.7	521.3	518.8	733.1	883.7	960.5	1,101.7	1,264.8
Income Tax % effective tax rate	31.8 33.0%	45.2 33.9%	31.7 32.3%	47.6 30.1%	55.2 27.4%	70.5 27.1%	76.7 25.3%	77.1 23.2%	78.0 20.2%	85.8 19.9%	83.0 19.0%	87.2 19.8%	76.5 18.3%	205.7 39.5%	114.3 22.0%	111.4 15.2%	409.2 46.3%	181.0 18.8%	204.1 18.5%	243.8 19.3%
Net Income % margin	64.8 15.2%	88.2 14.5%	66.3 9.3%	110.3 13.2%	146.4 15.9%	190.1 17.4%	227.0 18.3%	254.9 18.6%	307.1 20.3%	345.3 22.2%	352.9 21.0%	352.4 19.2%	342.3 16.6%	315.6 13.5%	404.6 15.5%	621.7 21.0%	474.5 14.8%	779.4 21.8%	897.6 21.3%	1,021.0 21.8%
EPS	0.47	0.61	0.43	0.72	0.97	1.26	1.49	1.75	2.15	2.44	2.51	2.51	2.42	2.21	2.83	4.31	3.27	5.34	6.12	6.94
Diluted EPS	0.46	0.58	0.43	0.70	0.95	1.23	1.44	1.71	2.10	2.39	2.47	2.49	2.40	2.19	2.80	4.27	3.24	5.30	6.09	6.92
EBITDA % margin	136.9 32.2%	174.0 28.7%	90.2 12.6%	204.8 24.5%	190.3 20.7%	322.2 29.5%	374.3 30.1%	422.6 30.9%	469.8 31.0%	484.9 31.2%	482.3 28.7%	522.7 28.4%	568.9 27.5%	680.2 29.1%	705.8 27.1%	990.4 33.5%	1,099.2 34.4%	1,176.6 32.9%	1,358.8 32.2%	1,533.5 32.7%

Discover more Stock Ideas

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%

S&P Outperformance 19.1%

Next 3M Predicted Return 20.3%

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%

S&P Outperformance 22.3%

Next 3M Predicted Return 26.8%

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%

S&P Outperformance 15.4%

Next 3M Predicted Return 16.9%

More ideas -->

FAQ

1) What is ResMed Inc.'s P/Revenue LTM?

As of today, Microsoft Corp's last 12-month P/Revenue LTM is 7.0x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual P/Revenue LTM for ResMed Inc. have been 8.5x over the past three years, and 9.0x over the past five years.

2) Is ResMed Inc.'s P/Revenue LTM Good?

As of today, ResMed Inc.'s P/Revenue LTM is 7.0x, which is higher than industry median of 3.5x. It indicates that ResMed Inc.'s P/Revenue LTM is Bad.

3) How does ResMed Inc.'s P/Revenue LTM compare to its peers?

As of today, ResMed Inc.'s P/Revenue LTM is 7.0x, which is higher than peer median of 4.7x. The list of peers includes ISRG, RGEN, WST, MASI, COO, ALC, HOLX, BDX, ATR, BAX.

#ResMed Inc. P/Revenue LTM

#ResMed Inc. (RMD) P/Revenue LTM comparison analysis

General

LTM P/Revenue LTM

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

#RMD key stats

#Discover more Stock Ideas